Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells

Sheng Chun Ye, Jason M. Foster, WenHui Li, JiuRong Liang, Elizabeth Zborowska, Srinivas Venkateswarlu, JianGen Gong, Michael G. Brattain, James K V Willson

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Transforming growth factor βs (TGF-βs) are a growth factor family with negative autocrine growth functions for most epithelial cells including colon carcinoma cell lines. Both type I (RI) and type II (RII) transmembrane TGF-β receptors have been shown to be indispensable for TGF-β-mediated cell growth regulation. Previous studies using different model systems have shown that both overexpression of TGF-β and transfection of antisense TGF-β1 to reduce TGF-β1 expression could lead to increased tumorigenicity. These results are seemingly contradictory and suggest that effects of TGF-β modulation on malignant properties of cancer cells may be contextual. This study addresses this issue using human colon carcinoma cells (CBS and FET) to determine the effects of modulation of the various components of the TGF-β system on in vitro and in vivo growth properties in two independent isogenic models of colon carcinoma. Cells were stably transfected with a tetracycline- repressible RII expression vector (CBS4-RII), a tetracycline-repressible expression vector containing a truncated RII cDNA lacking the serine/threonine kinase domain (CBS4-ΔRII and FET6-ΔRII), or with a vector containing the TGF-β1 cDNA (CBS4-β1S and FET-β1S). Expression of the truncated RII reduced TGF-β sensitivity, whereas overexpression of RII increased TGF-β sensitivity. TGF-β overexpression did not affect TGF-β response. In vivo tumorigenicity assays revealed that CBS4-RII cells had lower tumorigenicity than control cells, whereas CBS4-ΔRII and CBS4β1S had higher tumorigenicity than controls. The CBS4 cells are poorly tumorigenic in athymic mice, and the wild-type FET6 cells are nontumorigenic. FET6-ΔRII cells formed rapidly growing tumors, and FETβ1S cells also formed tumors. These data illustrate the paradoxical tumor-promoting and -suppressing effects of TGF-β signaling activity in two isogenic model systems from human colon carcinomas, thus demonstrating that the effects of modulation of TGF-β expression or TGF-β signaling capability affects malignancy in a contextual manner.

Original languageEnglish (US)
Pages (from-to)4725-4731
Number of pages7
JournalCancer Research
Volume59
Issue number18
StatePublished - Sep 15 1999

Fingerprint

Transforming Growth Factors
Colon
Carcinoma
Neoplasms
Tetracycline
Growth
Complementary DNA
Protein-Serine-Threonine Kinases
Nude Mice
Transfection
Intercellular Signaling Peptides and Proteins
Epithelial Cells
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ye, S. C., Foster, J. M., Li, W., Liang, J., Zborowska, E., Venkateswarlu, S., ... Willson, J. K. V. (1999). Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells. Cancer Research, 59(18), 4725-4731.

Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells. / Ye, Sheng Chun; Foster, Jason M.; Li, WenHui; Liang, JiuRong; Zborowska, Elizabeth; Venkateswarlu, Srinivas; Gong, JianGen; Brattain, Michael G.; Willson, James K V.

In: Cancer Research, Vol. 59, No. 18, 15.09.1999, p. 4725-4731.

Research output: Contribution to journalArticle

Ye, SC, Foster, JM, Li, W, Liang, J, Zborowska, E, Venkateswarlu, S, Gong, J, Brattain, MG & Willson, JKV 1999, 'Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells', Cancer Research, vol. 59, no. 18, pp. 4725-4731.
Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S et al. Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells. Cancer Research. 1999 Sep 15;59(18):4725-4731.
Ye, Sheng Chun ; Foster, Jason M. ; Li, WenHui ; Liang, JiuRong ; Zborowska, Elizabeth ; Venkateswarlu, Srinivas ; Gong, JianGen ; Brattain, Michael G. ; Willson, James K V. / Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells. In: Cancer Research. 1999 ; Vol. 59, No. 18. pp. 4725-4731.
@article{7dd2ae8d61774cb0ac52c3f7cd7a2280,
title = "Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells",
abstract = "Transforming growth factor βs (TGF-βs) are a growth factor family with negative autocrine growth functions for most epithelial cells including colon carcinoma cell lines. Both type I (RI) and type II (RII) transmembrane TGF-β receptors have been shown to be indispensable for TGF-β-mediated cell growth regulation. Previous studies using different model systems have shown that both overexpression of TGF-β and transfection of antisense TGF-β1 to reduce TGF-β1 expression could lead to increased tumorigenicity. These results are seemingly contradictory and suggest that effects of TGF-β modulation on malignant properties of cancer cells may be contextual. This study addresses this issue using human colon carcinoma cells (CBS and FET) to determine the effects of modulation of the various components of the TGF-β system on in vitro and in vivo growth properties in two independent isogenic models of colon carcinoma. Cells were stably transfected with a tetracycline- repressible RII expression vector (CBS4-RII), a tetracycline-repressible expression vector containing a truncated RII cDNA lacking the serine/threonine kinase domain (CBS4-ΔRII and FET6-ΔRII), or with a vector containing the TGF-β1 cDNA (CBS4-β1S and FET-β1S). Expression of the truncated RII reduced TGF-β sensitivity, whereas overexpression of RII increased TGF-β sensitivity. TGF-β overexpression did not affect TGF-β response. In vivo tumorigenicity assays revealed that CBS4-RII cells had lower tumorigenicity than control cells, whereas CBS4-ΔRII and CBS4β1S had higher tumorigenicity than controls. The CBS4 cells are poorly tumorigenic in athymic mice, and the wild-type FET6 cells are nontumorigenic. FET6-ΔRII cells formed rapidly growing tumors, and FETβ1S cells also formed tumors. These data illustrate the paradoxical tumor-promoting and -suppressing effects of TGF-β signaling activity in two isogenic model systems from human colon carcinomas, thus demonstrating that the effects of modulation of TGF-β expression or TGF-β signaling capability affects malignancy in a contextual manner.",
author = "Ye, {Sheng Chun} and Foster, {Jason M.} and WenHui Li and JiuRong Liang and Elizabeth Zborowska and Srinivas Venkateswarlu and JianGen Gong and Brattain, {Michael G.} and Willson, {James K V}",
year = "1999",
month = "9",
day = "15",
language = "English (US)",
volume = "59",
pages = "4725--4731",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Contextual effects of transforming growth factor β on the tumorigenicity of human colon carcinoma cells

AU - Ye, Sheng Chun

AU - Foster, Jason M.

AU - Li, WenHui

AU - Liang, JiuRong

AU - Zborowska, Elizabeth

AU - Venkateswarlu, Srinivas

AU - Gong, JianGen

AU - Brattain, Michael G.

AU - Willson, James K V

PY - 1999/9/15

Y1 - 1999/9/15

N2 - Transforming growth factor βs (TGF-βs) are a growth factor family with negative autocrine growth functions for most epithelial cells including colon carcinoma cell lines. Both type I (RI) and type II (RII) transmembrane TGF-β receptors have been shown to be indispensable for TGF-β-mediated cell growth regulation. Previous studies using different model systems have shown that both overexpression of TGF-β and transfection of antisense TGF-β1 to reduce TGF-β1 expression could lead to increased tumorigenicity. These results are seemingly contradictory and suggest that effects of TGF-β modulation on malignant properties of cancer cells may be contextual. This study addresses this issue using human colon carcinoma cells (CBS and FET) to determine the effects of modulation of the various components of the TGF-β system on in vitro and in vivo growth properties in two independent isogenic models of colon carcinoma. Cells were stably transfected with a tetracycline- repressible RII expression vector (CBS4-RII), a tetracycline-repressible expression vector containing a truncated RII cDNA lacking the serine/threonine kinase domain (CBS4-ΔRII and FET6-ΔRII), or with a vector containing the TGF-β1 cDNA (CBS4-β1S and FET-β1S). Expression of the truncated RII reduced TGF-β sensitivity, whereas overexpression of RII increased TGF-β sensitivity. TGF-β overexpression did not affect TGF-β response. In vivo tumorigenicity assays revealed that CBS4-RII cells had lower tumorigenicity than control cells, whereas CBS4-ΔRII and CBS4β1S had higher tumorigenicity than controls. The CBS4 cells are poorly tumorigenic in athymic mice, and the wild-type FET6 cells are nontumorigenic. FET6-ΔRII cells formed rapidly growing tumors, and FETβ1S cells also formed tumors. These data illustrate the paradoxical tumor-promoting and -suppressing effects of TGF-β signaling activity in two isogenic model systems from human colon carcinomas, thus demonstrating that the effects of modulation of TGF-β expression or TGF-β signaling capability affects malignancy in a contextual manner.

AB - Transforming growth factor βs (TGF-βs) are a growth factor family with negative autocrine growth functions for most epithelial cells including colon carcinoma cell lines. Both type I (RI) and type II (RII) transmembrane TGF-β receptors have been shown to be indispensable for TGF-β-mediated cell growth regulation. Previous studies using different model systems have shown that both overexpression of TGF-β and transfection of antisense TGF-β1 to reduce TGF-β1 expression could lead to increased tumorigenicity. These results are seemingly contradictory and suggest that effects of TGF-β modulation on malignant properties of cancer cells may be contextual. This study addresses this issue using human colon carcinoma cells (CBS and FET) to determine the effects of modulation of the various components of the TGF-β system on in vitro and in vivo growth properties in two independent isogenic models of colon carcinoma. Cells were stably transfected with a tetracycline- repressible RII expression vector (CBS4-RII), a tetracycline-repressible expression vector containing a truncated RII cDNA lacking the serine/threonine kinase domain (CBS4-ΔRII and FET6-ΔRII), or with a vector containing the TGF-β1 cDNA (CBS4-β1S and FET-β1S). Expression of the truncated RII reduced TGF-β sensitivity, whereas overexpression of RII increased TGF-β sensitivity. TGF-β overexpression did not affect TGF-β response. In vivo tumorigenicity assays revealed that CBS4-RII cells had lower tumorigenicity than control cells, whereas CBS4-ΔRII and CBS4β1S had higher tumorigenicity than controls. The CBS4 cells are poorly tumorigenic in athymic mice, and the wild-type FET6 cells are nontumorigenic. FET6-ΔRII cells formed rapidly growing tumors, and FETβ1S cells also formed tumors. These data illustrate the paradoxical tumor-promoting and -suppressing effects of TGF-β signaling activity in two isogenic model systems from human colon carcinomas, thus demonstrating that the effects of modulation of TGF-β expression or TGF-β signaling capability affects malignancy in a contextual manner.

UR - http://www.scopus.com/inward/record.url?scp=0033568528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033568528&partnerID=8YFLogxK

M3 - Article

C2 - 10493532

AN - SCOPUS:0033568528

VL - 59

SP - 4725

EP - 4731

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -